Bruker Corporation BRKR
63.79 USD +7.29 (+12.90%)
At closeNov 4, 2026, 4:00 PM EST
63.79 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
59.13 Day range 68.98
32.37 52-week range 68.98
- YTD
- +35.41%
- 1 year
- +57.97%
Analyst view
Consensus: buy
Buy
Price target (mean) 63.83 +0.1% upside
Now 63.79
- Target (low)
- 50.00
- Target (mean)
- 63.83
- Target (high)
- 80.00
Ratings (0m) 13 6 buy · 6 hold · 1 sell
- Strong buy1
- Buy5
- Hold6
- Sell1
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.90212 | 0.87 – 0.91289 | 0.59 | +52.9% | 1.03B | +5.1% | 12 |
| Next quarter | 0.4236 | 0.33178 – 0.56 | 0.31 | +36.7% | 853.31M | +3.6% | 8 |
| Current year | 2.12 | 2.10 – 2.14 | 1.83 | +15.8% | 3.56B | +3.5% | 13 |
| Next year | 2.40 | 2.28 – 2.47 | 2.12 | +13.4% | 3.70B | +4.2% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | JP Morgan | Downgrade | Overweight | Neutral |
| Oct 13, 2026 | TD Cowen | Maintained | Hold | Hold |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 29, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Sep 9, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 5, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 8, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 7, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 8, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 7, 2026 | UBS | Maintained | Neutral | Neutral |
| May 7, 2026 | Citigroup | Maintained | Neutral | Neutral |
| May 7, 2026 | TD Cowen | Maintained | Hold | Hold |
| May 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 15, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Mar 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 13, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Feb 13, 2026 | Goldman Sachs | Maintained | Sell | Sell |
| Feb 13, 2026 | TD Cowen | Maintained | Hold | Hold |
| Feb 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 26, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jan 16, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jan 7, 2026 | TD Cowen | Maintained | Hold | Hold |
| Jan 5, 2026 | Guggenheim | Maintained | Buy | Buy |
| Dec 15, 2025 | Barclays | Maintained | Overweight | Overweight |
| Dec 15, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Dec 15, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
